Crocs CEO's Trust Files to Sell $3.86M in Company Stock
CROX sits 60% above its 52-week low of $73.205.
Summary
Crocs CEO Andrew Rees's family trust plans to sell $3.86 million in company stock, marking a second significant insider sale in recent weeks as the stock approaches its 52-week high.
Key Events · Ownership and Investor Activity · CROX
-
Proposed Stock Sale by CEO's Trust
Andrew Rees, CEO of Crocs, through The Rees Family Living Trust U/A, intends to sell 32,688 shares of common stock, valued at approximately $3.86 million.
-
Recent Insider Selling Activity
This proposed sale follows a previous disposition of 5,000 shares by The Rees Family Foundation, Inc. on May 21, 2026, for gross proceeds of $538,418, both signed by Andrew Rees as Trustee.
-
Stock Trading Near 52-Week High
The filing occurs while Crocs' stock is trading near its 52-week high of $122.34, potentially influencing the timing of the sale.
Analysis · CROX · Manufacturing
Andrew Rees, CEO of Crocs, through his family living trust, has filed a Form 144 indicating intent to sell approximately $3.86 million worth of common stock. This proposed sale follows a previous disposition of 5,000 shares by a related foundation in May, suggesting a pattern of executive share disposition while the stock trades near its 52-week high.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CROX was trading at $116.97 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $73.21 to $122.34. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.